EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Defining the molecular response to ischemia-reperfusion injury and remote ischemic preconditioning in human kidney transplantation

Johan Nordström iD, Pau Badia-I-Mompel iD, Anna Witasp, Angelina Schwarz, Pieter Evenepoel, Matthias B Moor, Lars Wennberg, Julio Saez-Rodriguez, Annika Wernerson, Hannes Olauson

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0311613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Johan Nordström und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden. Hauptthemen laut MEDLINE: Kidney Transplantation, Reperfusion Injury, Ischemic Preconditioning. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Professor Lars-Erik Gelins memorial foundation, ME Transplantation Surgery research funding, Karolinska University Hospital, GSK and Sanofi and fees from Travere Therapeutics and Astex.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ischemia-reperfusion injury (IRI) inevitably occurs during kidney transplantation and extended ischemia is associated with delayed graft function and poor outcomes. Remote ischemic preconditioning (RIPC) is a simple, noninvasive procedure aimed at reducing IRI and improving graft function. Experimental studies have implicated the kynurenine pathway as a protective mechanism behind RIPC.

Methods

First, paired biopsies from 11 living kidney donors were analyzed to characterize the acute transcriptomic response to IRI. Second, 16 living kidney donors were subjected to either RIPC (n = 9) or no pretreatment (n = 7) to evaluate the impact of RIPC on the transcriptomic response to IRI. Finally, the effect of RIPC on plasma metabolites was analyzed in 49 healthy subjects.

Results

There was a robust immediate response to IRI in the renal transcriptomes of living-donor kidney transplantation, including activation of the mitogen-activated protein kinase (MAPK) and epidermal growth factor receptor (EGFR) pathways. Preconditioning with RIPC did not significantly alter the transcriptomic response to IRI or the concentration of plasma metabolites.

Conclusions

The present data validate living-donor kidney transplantation as a suitable model for mechanistic studies of IRI in human kidneys. The failure of RIPC to alter transcriptomic responses or metabolites in the kynurenine pathway raises the question of the robustness of the standard procedure used to induce RIPC, and might explain the mixed results in clinical trials evaluating RIPC as a method to attenuate IRI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationReperfusion InjuryIschemic PreconditioningHumansMaleFemaleMiddle AgedAdultLiving DonorsKidneyTranscriptomeKynurenine

Substanzen

Kynurenine

Autor:innen und Institutionen

  • Department of Transplantation Surgery, Karolinska University Hospital, Stockholm, Sweden.
  • Division of Transplantation Surgery, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
  • Institute for Computational Biomedicine, Bioquant, Faculty of Medicine, and Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.
  • Division of Renal Medicine, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden.
  • Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven, Belgium.
  • Department of Nephrology and Renal Transplantation, University Hospitals Leuven, KU Leuven, Belgium.

ORCID-Profile: Johan Nordström, Pau Badia-I-Mompel

Förderung

  • Professor Lars-Erik Gelins memorial foundation
  • ME Transplantation Surgery research funding, Karolinska University Hospital
  • GSK and Sanofi and fees from Travere Therapeutics and Astex
  • Stig and Gunborg Westman foundation
  • Tommy and Gösta Anderssons memorial foundation
  • The Swedish Research Council
  • CIMED
  • The Swedish Kidney Foundation

Zitieren

APA

Nordström, J., Badia-I-Mompel, P., Witasp, A., Schwarz, A., Evenepoel, P., Moor, M. B., Wennberg, L., Saez-Rodriguez, J., Wernerson, A., & Olauson, H. (2024). Defining the molecular response to ischemia-reperfusion injury and remote ischemic preconditioning in human kidney transplantation. PLOS ONE. https://doi.org/10.1371/journal.pone.0311613

Vancouver

Nordström J, Badia-I-Mompel P, Witasp A, Schwarz A, Evenepoel P, Moor MB, et al. Defining the molecular response to ischemia-reperfusion injury and remote ischemic preconditioning in human kidney transplantation. PLOS ONE. 2024. doi:10.1371/journal.pone.0311613

BibTeX
@article{Nordstrm2024,
  author = {Nordström, Johan and Badia-I-Mompel, Pau and Witasp, Anna and Schwarz, Angelina and Evenepoel, Pieter and Moor, Matthias B and Wennberg, Lars and Saez-Rodriguez, Julio and Wernerson, Annika and Olauson, Hannes},
  title = {Defining the molecular response to ischemia-reperfusion injury and remote ischemic preconditioning in human kidney transplantation},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0311613}
}
Kostenlos starten →